Chemokine receptor-derived peptides as multi-target drug leads for the treatment of inflammatory diseases

Peptides

Volumn 30, Issue 7, 2009, Pages 1296-1305

  Ezerzer, C ^a   Dolgin, M ^a   Skovorodnikova, J ^a   Harris, N ^a  

^a ProtAgonist Ltd   (Israel)

Author keywords

Chemokine; Disease; Inflammatory; Peptide

Indexed keywords

CHEMOKINE; CHEMOKINE BINDING PEPTIDE; CHEMOKINE RECEPTOR; DEXAMETHASONE; PEPTIDE P5R1; PEPTIDE P5R2; PEPTIDE P5R3; PEPTIDE P6R2; PEPTIDE P6R6; PEPTIDE P6XCR1; PEPTIDE P8R2; PEPTIDE P8R7; PEPTIDE P8XR3; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; COLITIS; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG EFFICACY; DRUG RESEARCH; DRUG SCREENING; DRUG TARGETING; FEMALE; HIGH THROUGHPUT SCREENING; INFLAMMATORY DISEASE; LIGAND BINDING; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PHAGE DISPLAY; PREDICTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; ANIMALS; CHEMOKINES; DRUG INTERACTIONS; FEMALE; INFLAMMATION; MICE; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; RECEPTORS, CHEMOKINE; SURFACE PLASMON RESONANCE;

ANIMALIA;

EID: 67349098006     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.03.016     Document Type: Article

References (33)

1. Asherson G.L., and Ptak W. Contact and delayed hypersensitivity in the mouse. I. Active sensitization and passive transfer. Immunology 15 (1968) 405-416
2. Attwood M., Borkakoti N., Bottomley G., Conway E., Cowan I., Fallowfield A., et al. Identification and characterisation of an inhibitor of interleukin-8: a receptor based approach. Bioorg Med Chem Lett 6 (1996) 1869-1874
3. Attwood M., Conway E., Dunsdon R., Greening J., Handa B., Jones P., et al. Peptide based inhibitors of interleukin-8: structural simplification and enhanced potency. Bioorg Med Chem Lett 7 (1997) 429-432
4. Auger G.A., Pease J.E., Shen X., Xanthou G., and Barker M.D. Alanine scanning mutagenesis of CCR3 reveals that the three intracellular loops are essential for functional receptor expression. Eur J Immunol 32 (2002) 1052-1058
5. Barabasi A.L., and Oltvai Z.N. Network biology: understanding the cell's functional organization. Nat Rev Genet 5 (2004) 101-113
6. Cox M.A., Jenh C.H., Gonsiorek W., Fine J., Narula S.K., Zavodny P.J., et al. Human interferon-inducible 10 kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states. Mol Pharmacol 59 (2001) 707-715
7. Estrada E. Virtual identification of essential proteins within the protein interaction network of yeast. Proteomics 6 (2006) 35-40
8. Ezerzer C., and Harris N. Physiological immunity or pathological autoimmunity-a question of balance. Autoimmun Rev 6 (2007) 488-496
9. Frantz S. Drug discovery: playing dirty. Nature 437 (2005) 942-943
10. Gayle III R.B., Sleath P.R., Srinivason S., Birks C.W., Weerawarna K.S., Cerretti D.P., et al. Importance of the amino terminus of the interleukin-8 receptor in ligand interactions. J Biol Chem 268 (1993) 7283-7289
11. Gerard C., and Rollins B.J. Chemokines and disease. Nat Immunol 2 (2001) 108-115
12. 8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 144 (1990) 4121-4128
13. Gribbon P., Lyons R., Laflin P., Bradley J., Chambers C., Williams B.S., et al. Evaluating real-life high-throughput screening data. J Biomol Screen 10 (2005) 99-107
14. Grosjean H., and Fiers W. Preferential codon usage in prokaryotic genes: the optimal codon-anticodon interaction energy and the selective codon usage in efficiently expressed genes. Gene 18 (1982) 199-209
15. Hopkins A.L. Network pharmacology. Nat Biotechnol 25 (2007) 1110-1111
16. Horuk R., and Ng H.P. Chemokine receptor antagonists. Med Res Rev 20 (2000) 155-168
17. Huang S. Genomics, complexity and drug discovery: insights from Boolean network models of cellular regulation. Pharmacogenomics 2 (2001) 203-222
18. Kim M.Y., Byeon C.W., Hong K.H., Han K.H., and Jeong S. Inhibition of the angiogenesis by the MCP-1 (monocyte chemoattractant protein-1) binding peptide. FEBS Lett 579 (2005) 1597-1601
19. Loetscher P., Pellegrino A., Gong J.H., Mattioli I., Loetscher M., Bardi G., et al. The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem 276 (2001) 2986-2991
20. Monteclaro F.S., and Charo I.F. The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation. J Biol Chem 271 (1996) 19084-19092
21. Neurath M., Fuss I., and Strober W. TNBS-colitis. Int Rev Immunol 19 (2000) 51-62
22. Ohlson S. Designing transient binding drugs: a new concept for drug discovery. Drug Discov Today 13 (2008) 433-439
23. Ohlson S., Strandh M., and Nilshans H. Detection and characterization of weak affinity antibody antigen recognition with biomolecular interaction analysis. J Mol Recognit 10 (1997) 135-138
24. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., and Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98 (1990) 694-702
25. Parrish J.R., Gulyas K.D., and Finley Jr. R.L. Yeast two-hybrid contributions to interactome mapping. Curr Opin Biotechnol 17 (2006) 387-393
26. Power C.A. Knock out models to dissect chemokine receptor function in vivo. J Immunol Met 273 (2003) 73-82
27. Ruffner H., Bauer A., and Bouwmeester T. Human protein-protein interaction networks and the value for drug discovery. Drug Discov Today 12 (2007) 709-716
28. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning a laboratory manual second edition. 2nd ed. (1989), Cold Spring Harbor Laboratory Press, New York p. 11803
29. Schwarz M.K., and Wells T.N. New therapeutics that modulate chemokine networks. Nat Rev Drug Discov 1 (2002) 347-358
30. Vasilescu J., and Figeys D. Mapping protein-protein interactions by mass spectrometry. Curr Opin Biotechnol 17 (2006) 394-399
31. Wallace J.L., MacNaughton W.K., Morris G.P., and Beck P.L. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 96 (1989) 29-36
32. Wells T.N., Power C.A., Shaw J.P., and Proudfoot A.E. Chemokine blockers-therapeutics in the making?. Trends Pharmacol Sci 27 (2006) 41-47
33. Williams D.P., Regier D., Akiyoshi D., Genbauffe F., and Murphy J.R. Design, synthesis and expression of a human interleukin-2 gene incorporating the codon usage bias found in highly expressed Escherichia coli genes. Nucleic Acids Res 16 (1988) 10453-10467